BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25706885)

  • 1. Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.
    Pole JD; Darmawikarta D; Gassas A; Ali M; Egler M; Greenberg ML; Doyle J; Nathan PC; Schechter T
    Bone Marrow Transplant; 2015 May; 50(5):721-6. PubMed ID: 25706885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years.
    Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
    Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
    PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
    Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
    Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late mortality after hematopoietic SCT for a childhood malignancy.
    Schechter T; Pole JD; Darmawikarta D; Doyle J; Ali M; Egeler M; Gassas A; Irwin MS; Greenberg M; Nathan PC
    Bone Marrow Transplant; 2013 Oct; 48(10):1291-5. PubMed ID: 23665822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction.
    Zamora-Ortiz G; Velázquez-Sánchez-de-Cima S; Ponce-de-León S; Gutiérrez-Aguirre CH; Ruiz-Delgado GJ; Gomez-Almaguer D; Ruiz-Argüelles GJ
    Hematology; 2014 Dec; 19(8):435-40. PubMed ID: 24552480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group.
    Faraci M; Bagnasco F; Corti P; Messina C; Fagioli F; Podda M; Prete A; Caselli D; Lanino E; Dini G; Rondelli R; Haupt R;
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1271-6. PubMed ID: 19747635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation.
    Song JS; London WB; Hawryluk EB; Guo D; Sridharan M; Fisher DE; Lehmann LE; Duncan CN; Huang JT
    Bone Marrow Transplant; 2017 Jul; 52(7):989-997. PubMed ID: 28368380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignancies after autologous hematopoietic cell transplantation in children.
    Danner-Koptik KE; Majhail NS; Brazauskas R; Wang Z; Buchbinder D; Cahn JY; Dilley KJ; Frangoul HA; Gross TG; Hale GA; Hayashi RJ; Hijiya N; Kamble RT; Lazarus HM; Marks DI; Reddy V; Savani BN; Warwick AB; Wingard JR; Wood WA; Sorror ML; Jacobsohn DA
    Bone Marrow Transplant; 2013 Mar; 48(3):363-8. PubMed ID: 22964594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
    Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
    Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
    Borgmann A; Zinn C; Hartmann R; Herold R; Kaatsch P; Escherich G; Möricke A; Henze G; von Stackelberg A;
    Eur J Cancer; 2008 Jan; 44(2):257-68. PubMed ID: 17981026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma.
    Fujita N; Kobayashi R; Atsuta Y; Iwasaki F; Suzumiya J; Sasahara Y; Inoue M; Koh K; Hori T; Goto H; Ichinohe T; Hashii Y; Kato K; Suzuki R; Mitsui T
    Int J Hematol; 2019 Apr; 109(4):483-490. PubMed ID: 30701466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
    Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
    Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
    Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
    JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy.
    Nelson AS; Ashton LJ; Vajdic CM; Le Marsney RE; Daniels B; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
    Leukemia; 2015 Feb; 29(2):441-7. PubMed ID: 24962016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second malignant neoplasm following childhood cancer: A nested case-control study of a recent cohort (1987-2004) from the Childhood Cancer Registry of the Rhône-Alpes region in France.
    Casagranda L; Oriol M; Freycon F; Frappaz D; Bertrand Y; Bergeron C; Plantaz D; Stephan JL; Freycon C; Gomez F; Berger C; Trombert-Paviot B
    Pediatr Hematol Oncol; 2016 Sep; 33(6):371-382. PubMed ID: 27687523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.